Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 112,501	$ 100,066
General and administrative	33,098	30,647
Total operating expenses	145,599	130,713
Loss from operations	(145,599)	(130,713)
Interest and other income, net	3,652	390
Net loss	(141,947)	(130,323)
Net loss attributable to common stockholders	$ (141,947)	$ (130,323)
Net loss per share attributable to common stockholders, basic	$ (2.60)	$ (3.40)
Net loss per share attributable to common stockholders, diluted	$ (2.60)	$ (3.40)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic	54,673,572	38,316,273
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted	54,673,572	38,316,273